Synthesis of α-(aminomethylene)-9-(methoxymethyl)-9H-purine-6-acetic acid derivatives

α-(Aminomethylene)-9-(methoxymethyl)-9H-purine-6-acetamide and the ethyl acetate, 3 and 8 , have been synthesized by catalytic hydrogenation of 6-cyanomethylene-9-methoxymethylpurine derivatives 2 and 7 which were obtained by the substitution of 6-chloro-9-(methoxymethyl)purine ( 1 ) with α-cyanoacetamide and ethyl cyanoacetate, respectively. Substitution of 3 and 8 with amines gave the corresponding N-substituted α-(aminomethylene)-9-(methoxymethyl)-9H-purine-6-acetamide and the ethyl acetate 4 and 10 . Reaction of 3 with piperidine gave 9-(methoxymethyl)-9H-purine-6-acetamide ( 5 ).     

Purinenucleoside analogs. 2. 9-(1-Alkoxyethyl-1)-6-substituted purines

Vinyl ethers react with 6-chloro- and 6-methylthiopurines in acid medium to give 9-(1-alkoxyethyl-1)-6-chloro- and 6-methylthiopurines. The 6-chloro compounds were used to prepare 9-(1-alkoxyethyl-1)-6-mercaptopurines. All the synthesized compounds proved to be inactive against lympholeucosis P 388, and Lewis carcinona grafted under kidney capsules in mice.For Communication 1, see [1].Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 3, pp. 403–406, March, 1986.     

Synthesis of 9-(2-fluorobenzyl)-6-methylamino-9H-purine

Synthesis of 9-(2-fluorobenzyl)-6-methylamino-9H-purine ( 1 ) from nine different precursors is reported. Compound 1 was prepared by methylamination of 6-chloro-9-(2-fluorobenzyl)-9H-purine ( 4 ), by alkylation of 6-methylaminepurine ( 5 ) or form 9-(2-fluorobenzyl)-1-methyladeninium iodide ( 8 ) via the Dimroth rearrangement. Selective 2-step methylation of 6-aminopurine 6 was accomplished by hydride reduction of 6-formamidopurine 9 , 6-dimethylaminomethyleneaminopurine 10 or 6-phenylthiomethyl purine 11 to give 1. Compound 1 was also prepared by dethiation or reductive dechlorination of 2-methylthiopurine 16 or 8-chloropurine 19 , respectively, or by hydrolysis of 6-N-methylformamidopurine 12 , which was prepared from 6-dimethylaminopurine 13 by selective oxidation.     

合成抗孕酮新药RU—486中间体3,3—乙撑二氧—5α,10α及5？…

采用薄层色谱成功地分离了３,３－乙撑二氧－△＾５（１０）,９（１１）－雌甾二烯－１７α（１－丙炔基）－１７β醇的环氧化产物３,３－乙撑二氧－５α,１０α－环氧－△＾９（１１）－雌烯－１７α（１－丙烯基）－１７β醇（简称Ｉα）和３,３－乙撑二氧－５β,１０β－环氧－△＾９（１１）－雌烯－１７α（１－丙炔基）－１７β醇（简称Ｉβ）,并对Ｉα和Ｉβ进行了定性和定量分析,其结果在红外谱图、核磁实验中得到验     

Ten-vertex iron-monocarbollide complexes: synthesis and reactivity of the anion [4,9-{Fe(CO)4}-9,9,9-(CO)3-arachno-9,6-FeCB8H11]-

The reagent [arachno-4-CB8H14] reacts with [Fe3(CO)12] in tetrahydrofuran (THF) at reflux temperatures, followed by addition of [N(PPh3)2]Cl, to afford [N(PPh3)2][4,9-{Fe(CO)4}-9,9,9-(CO)3-arachno-9,6-FeCB8H11] (3). In the anion of 3, one iron atom is part of the open CBBFeBB face of a 10-vertex {arachno-9,6-FeCB8} cage, to which the second iron atom is attached via an Fe-Fe bond and an additional exo-polyhedral Fe-B sigma bond. Upon heating 3 in refluxing toluene, the closed 10-vertex species [N(PPh3)2][2,2,2-(CO)3-closo-2,1-FeCB8H9] (4) is obtained, whereas the isomeric compound [N(PPh3)2][6,6,6-(CO)3-closo-6,1-FeCB8H9] (5) is isolated upon heating [closo-4-CB8H9]- and [Fe3(CO)12] in refluxing THF with subsequent addition of [N(PPh3)2]Cl. Protonation of 3 using CF3SO3H in CH2Cl2 gives the charge-compensated compound [4,9-{Fe(CO)4}-4-(mu-H)-9,9,9-(CO)3-arachno-9,6-FeCB8H11] (6), in which the B-Fe sigma bond of the precursor has been converted to a B-H right harpoon-up Fe linkage. In contrast, 3 with {M(PPh3)}+ gives the trimetallic species [1,3,4,9-{MFe(CO)4(PPh3)}-1,3-(mu-H)2-9,9,9-(CO)3-arachno-9,6-FeCB8H9] (M = Cu (7), Ag 8) in which the three metal centers form a V-shaped M-Fe-Fe unit. Compound 6 reacts with PEt3 in the presence of Me(3)NO to yield [4,9-(PEt3)2-9,9-(CO)2-nido-9,6-FeCB8H10] (9). In the latter, the formerly exo-polyhedral {Fe(CO)4} fragment has been replaced by a PEt3 ligand, with a second PEt3 substituting one CO group at the remaining cluster iron vertex. The novel structural features of compounds 3-9 have been confirmed by single-crystal X-ray diffraction studies.     

The intramolecular thermal ene reaction route to (+)-9(O)-methano-Δ6(9α) -PGI1

(+)-9(O)-Methano-Δ^6(9α)-PGI₁, a more potent carbon analog than carbacyclin, has been synthesized from the Corey lactone by utilizing the intramolecular thermal ene reaction as a key step.     

First chemoenzymatic synthesis of (R)- and (S)-1-(9H-fluoren-9-yl)ethanol

A simple chemoenzymatic synthesis of 1-(9H-fluoren-9-yl)ethanol stereoisomers is described. The enantiomers were resolved by a kinetically controlled transesterification with vinyl acetate in the presence of commercially available lipases. High-throughput screening and subsequent exhaustive investigation of the utility of the lipases in a stereoselective process of introducing chirality have been carried out. Lipase A from Candida antarctica as a cross-linked aggregate (CAL-A-CLEA) was the most efficient enzyme for the resolution of the title compound providing (S)-1-(9H-fluoren-9-yl)ethanol and its (R)-acetate in enantiopure form (>99% ee). Under mild reaction conditions, excellent enantioselectivity (E = 407), and good isolated yields of the products were obtained.     

Synthesis of 3-(6-alkylaminopurin-9-yl)-2,3-dideoxy-D-thero-pentopyranoses and their reduction to 3-(6-alkylaminopurin-9-yl)-2,3-dideoxy-D-thero-pentitols

3-(6-Alkylaminopurin-9-yl)-2,3-dideoxy-D-threo-pentopyranoses 3 were prepared by condensation of unprotected 2-deoxy-D-ribose (2) with N⁶-alkyladenines 1 in a phosphorus pentoxide reagent mixture. Reduction of the pentoses 3 gave the corresponding 3-(6-alkylaminopurin-9-yl)-2,3-dideoxy-D-threo-pentitols 4. The structures of 3 and 4 were determined by ¹³C nmr, ¹H nmr and 2D ¹H nmr (COSY).     

Synthesis of D-(6R) - and D-(6S) -(6-2H1) glucose

Chemical synthesis ofD-(6R)- and D(6S)-(6-²H₁) glucose is described comprising (i) formation of 6-²H₁)-3-o-benzyl-5,6-dideoxy-l, 2-0-isopropylidene-α-D-xylo-hex-5-ynofuranose from D-glucose; (ii) stereospecific reduction of the deuterated acetylene functionality to (E)- or (Z)-deuterated olefin; (iii) stereospecific cis-dihydroxylation of the deuterated olefin; and (iv) separation of stereoisomers based on the intrinsic chirality of D-glucose and subsequent deprotection.